Compare CBNK & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBNK | CTKB |
|---|---|---|
| Founded | 1974 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 520.4M | 595.2M |
| IPO Year | 2018 | 2021 |
| Metric | CBNK | CTKB |
|---|---|---|
| Price | $31.43 | $4.92 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $35.50 | $5.63 |
| AVG Volume (30 Days) | 58.6K | ★ 533.2K |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | ★ 60.85 | N/A |
| EPS | ★ 3.41 | N/A |
| Revenue | N/A | ★ $193,015,000.00 |
| Revenue This Year | $16.20 | $5.42 |
| Revenue Next Year | $8.52 | $7.03 |
| P/E Ratio | $9.19 | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $26.40 | $2.37 |
| 52 Week High | $36.40 | $6.18 |
| Indicator | CBNK | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 52.87 | 64.12 |
| Support Level | $30.18 | $4.90 |
| Resistance Level | $33.46 | $5.24 |
| Average True Range (ATR) | 0.82 | 0.22 |
| MACD | -0.10 | 0.03 |
| Stochastic Oscillator | 45.92 | 92.70 |
Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage. The company generates majority revenue from the Commercial bank sector. Commercial Banking division focuses on providing personalized service to commercial clients throughout the operations supplemented by lending outside primary market as well as engaging in government guaranteed lending on a national basis.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.